{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:40:34Z","timestamp":1782974434780,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.dld.2025.10.026","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:06:42Z","timestamp":1762211202000},"page":"2304-2320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Mohammad Al","family":"Hayek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0113-5117","authenticated-orcid":false,"given":"Mohammed S.","family":"Beshr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamedhen Vall","family":"Nounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Manuela","family":"Estevinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Kayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Frias-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-5139","authenticated-orcid":false,"given":"Johan","family":"Burisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1572-0118","authenticated-orcid":false,"given":"Alessandro","family":"Armuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6751-619X","authenticated-orcid":false,"given":"Bisher","family":"Sawaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4171-5751","authenticated-orcid":false,"given":"Mulham","family":"Alom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7681-8111","authenticated-orcid":false,"given":"Miguel","family":"Regueiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7199-6851","authenticated-orcid":false,"suffix":"Jr","given":"Edward V.","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6406-4212","authenticated-orcid":false,"given":"Muhammed","family":"Elhadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2025.10.026_bib0001","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bpg.2018.05.007","article-title":"Acute severe ulcerative colitis: state of the art treatment","author":"Gisbert","year":"2018","journal-title":"Best Pr Res Clin Gastroenterol"},{"key":"10.1016\/j.dld.2025.10.026_bib0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/apt.15592","article-title":"Systematic review with meta-analysis: mortality in acute severe ulcerative colitis","volume":"51","author":"Dong","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.10.026_bib0003","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/s41395-018-0057-0","article-title":"Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: nationwide multicenter study of the GETECCU ENEIDA Registry","volume":"113","author":"Ord\u00e1s","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.10.026_bib0004","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/SLA.0000000000002628","article-title":"Postoperative mortality after nonelective surgery for inflammatory bowel disease patients in the era of biologics","volume":"269","author":"Justiniano","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.dld.2025.10.026_bib0005","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO Guidelines on therapeutics in ulcerative colitis: surgical treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2025.10.026_bib0006","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ueg2.12442","article-title":"Review article: updated management of acute severe ulcerative colitis: from steroids to novel medical strategies","volume":"11","author":"Calm\u00e9jane","year":"2023","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2025.10.026_bib0007","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nrgastro.2016.116","article-title":"Acute severe ulcerative colitis: from pathophysiology to clinical management","volume":"13","author":"Hindryckx","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0008","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/gutjnl-2016-313060","article-title":"Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab","volume":"67","author":"Laharie","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.dld.2025.10.026_bib0009","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","article-title":"Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial","volume":"1","author":"Williams","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0010","doi-asserted-by":"crossref","DOI":"10.1177\/17562848251323511","article-title":"Sequential rescue therapy with JAK inhibitors in corticosteroid and infliximab-refractory acute severe ulcerative colitis: a case series","volume":"18","author":"Etchegaray","year":"2025","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.dld.2025.10.026_bib0011","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjaf021","article-title":"Janus kinase inhibitors in the management of acute severe ulcerative colitis: a comprehensive review","volume":"19","author":"Gisbert","year":"2025","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2025.10.026_bib0012","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/ecco-jcc\/jjad004","article-title":"Rescue therapies for steroid-refractory acute severe ulcerative colitis: a review","volume":"17","author":"Gisbert","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2025.10.026_bib0013","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"10.1016\/j.dld.2025.10.026_bib0014","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.dld.2025.10.026_bib0015","unstructured":"Covidence systematic review software VHI, Melbourne, Australia. (2025). Available at www.covidence.org."},{"key":"10.1016\/j.dld.2025.10.026_bib0016","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2025.10.026_bib0017","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.dld.2025.10.026_bib0018","series-title":"The newcastle-ottawa scale (NOS)","year":"2021"},{"key":"10.1016\/j.dld.2025.10.026_bib0019","unstructured":"Rohatgi A. Webplotdigitizer, Version 4.5. URL https:\/\/automerisio\/WebPlotDigitizer 2020;411:860."},{"key":"10.1016\/j.dld.2025.10.026_bib0020","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12874-021-01308-8","article-title":"IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.dld.2025.10.026_bib0021","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.dld.2025.10.026_bib0022","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13643-017-0473-z","article-title":"Approaches to interpreting and choosing the best treatments in network meta-analyses","volume":"6","author":"Mbuagbaw","year":"2017","journal-title":"Syst Rev"},{"key":"10.1016\/j.dld.2025.10.026_bib0023","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.dld.2025.10.026_bib0024","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(12)61084-8","article-title":"Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial","volume":"380","author":"Laharie","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2025.10.026_bib0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S2468-1253(24)00200-0","article-title":"Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial","volume":"9","author":"Choy","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0026","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/apt.17938","article-title":"Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)","volume":"59","author":"Garc\u00eda","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.10.026_bib0027","article-title":"Comparison of accelerated and standard infliximab induction regimens in acute severe ulcerative colitis using propensity score analysis: a retrospective multicenter study in China","author":"Liu","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.dld.2025.10.026_bib0028","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s10620-018-5358-z","article-title":"High-dose Infliximab rescue therapy for hospitalized acute severe ulcerative colitis does not improve colectomy-free survival","volume":"64","author":"Chao","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.10.026_bib0029","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/apt.12375","article-title":"Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab","volume":"38","author":"Croft","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.10.026_bib0030","first-page":"601","article-title":"Infliximab versus Cyclosporine treatment for severe corticosteroid-refractory ulcerative colitis: a Korean, retrospective, single center study","volume":"9","author":"Kim","year":"2015","journal-title":"Gut Liver"},{"key":"10.1016\/j.dld.2025.10.026_bib0031","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/jgh.15508","article-title":"Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis","volume":"36","author":"Song","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0032","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.crohns.2011.11.021","article-title":"Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: early and long-term data from a retrospective observational study","volume":"6","author":"Mocciaro","year":"2012","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2025.10.026_bib0033","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10620-020-06177-7","article-title":"Hypoalbuminemia and bandemia predict failure of Infliximab rescue therapy in acute severe ulcerative colitis","volume":"66","author":"Syal","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2025.10.026_bib0034","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/ajg.2017.180","article-title":"Long-term efficacy and safety of cyclosporine in a cohort of steroid-refractory acute severe ulcerative colitis patients from the ENEIDA Registry (1989-2013): a nationwide multicenter study","volume":"112","author":"Ord\u00e1s","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.10.026_bib0035","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1440-1746.2011.06958.x","article-title":"Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis","volume":"27","author":"Dean","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0036","first-page":"370","article-title":"Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center study","volume":"34","author":"Grazie","year":"2021","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.dld.2025.10.026_bib0037","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/jgh.14072","article-title":"Predicting response after infliximab salvage in acute severe ulcerative colitis","volume":"33","author":"Choy","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0038","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/apt.15456","article-title":"Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis","volume":"50","author":"Sebastian","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2025.10.026_bib0039","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cgh.2018.06.031","article-title":"Effect of accelerated Infliximab induction on short- and long-term outcomes of acute severe ulcerative colitis: a retrospective multicenter study and meta-analysis","volume":"17","author":"Nalagatla","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cgh.2014.07.041","article-title":"An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis","volume":"13","author":"Gibson","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0041","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.10.026_bib0042","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/ibd\/izad183","article-title":"Factors associated with response to rescue therapy in acute severe ulcerative colitis","volume":"30","author":"Li Wai Suen","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2025.10.026_bib0043","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2020.01.007","article-title":"AGA technical review on the management of moderate to severe ulcerative colitis","volume":"158","author":"Singh","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2025.10.026_bib0044","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14309\/ajg.0000000000002635","article-title":"Tofacitinib in acute severe ulcerative colitis (TACOS): a randomized controlled trial","volume":"119","author":"Singh","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2025.10.026_bib0045","doi-asserted-by":"crossref","DOI":"10.1093\/ecco-jcc\/jjae111","article-title":"Rescue therapies for steroid-refractory acute severe ulcerative colitis: a systemic review and network meta-analysis","author":"Huang","year":"2024","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2025.10.026_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2025.03.007","article-title":"Medical therapy for acute severe ulcerative colitis: a systematic review with meta-analysis","author":"Vuyyuru","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2025.10.026_bib0047","article-title":"Systematic review and Meta-analysis: infliximab or Cyclosporine as rescue therapy in patients with severe ulcerative colitis refractory to steroids","volume":"111","author":"Narula","year":"2016","journal-title":"Off j Am Coll Gastroenterol | ACG"},{"key":"10.1016\/j.dld.2025.10.026_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2019.00338","article-title":"Comparable long-term outcomes of Cyclosporine and Infliximab in patients with steroid-refractory acute severe ulcerative colitis: a meta-analysis","author":"Szemes","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.dld.2025.10.026_bib0049","doi-asserted-by":"crossref","first-page":"G612","DOI":"10.1152\/ajpgi.90576.2008","article-title":"Infliximab and the TNF-alpha system","volume":"296","author":"Ebert","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.dld.2025.10.026_bib0050","unstructured":"Safarini OA, Keshavamurthy C, Patel P, Calcineurin Inhibitors. 2023 Nov 12. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025."},{"key":"10.1016\/j.dld.2025.10.026_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2025.07.025","article-title":"Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis","author":"Honap","year":"2025","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825011855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865825011855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T14:24:10Z","timestamp":1766154250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865825011855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1590865825011855"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2025.10.026","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of immunomodulators, biologics, and advanced therapies for steroid-refractory acute severe ulcerative colitis: A network meta-analysis and time-to-event analysis","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2025.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}